Targacept to begin Phase 2 trials of drug that could treat asthma, diabetes – Winston-Salem Journal

Targacept to begin Phase 2 trials of drug that could treat asthma, diabetes
Winston-Salem Journal
Type 2 diabetes affects 198 million worldwide, and asthma affects about 65 million in just the world's seven major pharmaceutical markets — France, Germany
Targacept starts new trial for diabetes drugBizjournals.com
TARGACEPT : Announces Initiation of Phase 2 Studies of TC-6987 in Asthma and 4-traders (press release)

all 17 news articles »

View full post on asthma – Google News

Targacept to begin phase 2 trials for its anti-inflammatory drug compound – Winston-Salem Journal

Targacept to begin phase 2 trials for its anti-inflammatory drug compound
Winston-Salem Journal
said that the studies involve its drug compound TC-6987 for disorders related to inflammation – in this instance asthma and Type 2 diabetes.
Targacept starts new trial for diabetes drugBizjournals.com
TARGACEPT : Announces Initiation of Phase 2 Studies of TC-6987 in Asthma and 4-traders (press release)

all 13 news articles »

View full post on asthma – Google News